PHYTOTHERAPEUTIC PHARMACEUTICAL ASSOCIATION, PHYTOTHERAPEUTIC PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING PHYTOTHERAPE PHARMACEUTICAL COMPOSITION AND ITS APPLICATION IN VETERINARY

摘要

1. A phytotherapeutic pharmaceutical association, characterized in that it contains the essential oil Lippia salvifolia and Lippia sidoides in the range from 9: 1 to 1: 9, so as to provide at least 50% thymol and 5% carvacrol. 2. The phytotherapeutic pharmaceutical association according to claim 1, characterized in that the proportional ratio of the essential oil of Lippia salvifolia and Lippia sidoides is approximately 9: 1.3. The use of the phytotherapeutic pharmaceutical association according to claim 1 or 2, characterized in that it is intended for the production of a veterinary medicinal product for controlling microorganisms. 4. The use of the phytotherapeutic pharmaceutical association according to claim 3, characterized in that the microorganism is Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis and Candida albicans, or a combination thereof. A phytotherapeutic pharmaceutical composition, characterized in that the active ingredient contains the total amount of essential oils Lippia salvifolia and Lippia sidoides, varying in the range from 0.1 to 10.0% by weight, and pharmaceutically acceptable carriers and excipients. 6. The phytotherapeutic pharmaceutical composition according to claim 5, characterized in that as the active ingredient contains the total amount of essential oils Lippia salvifolia and Lippia sidoides, varying in the range from 0.5 to 2.0% by weight. The phytotherapeutic pharmaceutical composition according to claim 5 or 6, characterized in that it provides at least 50% thymol and at least 5% carvacrol. The phytotherapeutic pharmaceutical composition according to claim 5, characterized in that it contains in mass percent 0-99.89% by weight of emollients / solvent